Delivery Order SPE2DB22D3016-SPE2DB24FATF0
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,811.52, is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,535,197 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,339,361 units of Lidocaine 5% Patch 30s, a pharmaceutical product. The $1,700.37 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 22, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $1,315.20 for the supply of 4,564,360,453 units of Lidocaine 5% Patch 30s. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the delivery of these pharmaceutical products by April 23, 2024. This contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4,564,097,616 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,604.39 firm fixed price delivery order has a completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,895,961 units of Lidocaine 5% Patch 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,077.30 and an ultimate completion date of June 14, 2024. It is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,589,836 units of Lidocaine 5% Patch 30S to the Defense Logistics Agency (DLA). The delivery order contract, valued at $2,746.98, was awarded on a firm fixed price basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,154,628 units of Lidocaine 5% Patch 30s. The contract has a ceiling value of $18,317.10 and a period of performance through May 7, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a part...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,911,136 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $6,476.85, has a completion date of June 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,634,345 units of Lidocaine 5% Patch 30s. The contract has a ceiling value of $10,275.69 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this contract to supply these medical products to support various government agencies and healthcare programs. The...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FATF0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,360,494 units of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $2,901.15, is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 7/22/24, 9:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 4/22/24 |